Briefing.com

Hourly In Play (R)

Updated: 18-May-26 00:00 ET

 Friday After the Close   
18:41  WRAPX This week's biggest % gainers/losers

The following are this week's top percentage gainers and losers, categorized by sectors (over $300 mln market cap and 100K average daily volume).

This week's top % gainers
  • Healthcare: MGNX (4.24 +41.17%), DERM (6.29 +24.06%), STAA (32.12 +20.34%)
  • Materials: BAK (4.89 +32.38%)
  • Industrials: ENPH (52.91 +45.16%), CSTE (1.71 +23.91%)
  • Consumer Discretionary: BZH (22.17 +18.11%), ARMK (53.18 +17.97%)
  • Information Technology: SEDG (61.68 +49.35%), TSEM (274.31 +29.99%), AAOI (189.29 +27.09%), DDD (3.03 +22.47%), CSCO (118.19 +22.39%), PANW (242.74 +16.77%), FN (724.63 +16.64%)
  • Energy: TUSK (3.21 +34.31%), KOS (3.25 +18%)
This week's top % losers
  • Healthcare: RGNX (5.72 -45.78%), FATE (1.77 -26.15%), STIM (1.30 -21.75%), SLP (13.27 -20.44%), PACB (1.13 -20.21%)
  • Industrials: REZI (28.24 -28.96%)
  • Consumer Discretionary: SNBR (1.6 -44.04%), EYE (17.44 -24.04%), JACK (10.8 -21.72%), UAA (5.15 -19.98%)
  • Information Technology: UPLD (0.73 -26.01%), SABR (1.59 -22.82%), CNDT (1.38 -21.88%)
  • Financials: PRAA (15.22 -20.65%)
  • Consumer Staples: EPC (16.01 -24.66%), BGS (4.20 -21.59%)
18:00  UTHR United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial (568.58 -7.21)

First-ever human clinical trial of a xenoheart intended to support potential registration through the submission of a Biologics License Application to the U.S. FDA
17:32  HBM Hudbay Minerals files mixed securities shelf offering (24.95 -2.34)

 
17:26  BMM Blue Moon Metals closes previously announced acquisition of claims adjacent to Springer Tungsten (6.70 -0.59)

  • Co has successfully closed its previously announced acquisition of 100% interest of certain claims adjacent to Springer (the "WO Claims") from GoldPlay LLC and Robert Schafer
17:25  AWK American Water Works files rate request driven by approximately $108 mln in continued investments (124.29 -1.69)

  • Kentucky American Water today filed a request with the Kentucky Public Service Commission (PSC) for new rates to support approximately $108 mln in ongoing water system investments from January 1, 2027, through December 31, 2027. The request reinforces the company's commitment to implementing critical system upgrades and continuing to improve water quality and reliability for its more than half a million people served.
17:17  GSAT Globalstar announces that the planned May 17 launch of its HIBLEO-4 replenishment satellites with SpaceX have been postponed (81.98 -0.10)

  • Co announces that the planned May 17 launch of its HIBLEO-4 replenishment satellites with SpaceX has been postponed to allow more time for Globalstar teams to prepare the satellites for launch. A new launch date will be shared once confirmed.
  • The mission remains focused on replenishing Globalstar's existing low Earth orbit constellation in support of continued network resilience and service reliability.
17:11  INSM Insmed files mixed securities shelf offering (109.14 -6.48)

 
16:52  PDFS PDF Solutions announces full exercise of Greenshoe option and closing of upsized public offering of common stock (44.65 -1.40)

  • The company announced the closing of its underwritten public offering of 5,253,554 shares of the Company's common stock at a public offering price of $44.00 per share, consisting of 1,946,630 shares sold by the Company and 3,306,924 shares sold by Advantest America, Inc. (ATEYY)
  • The gross proceeds to the Company from the sale of shares of common stock by the Company, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $85.7 mln.
16:38  WRAPX Closing Market Summary: Stocks pull back from record highs amid inflation concerns

Stocks ended a record-setting week on a lower note, with the S&P 500 (-1.2%), Nasdaq Composite (-1.5%), and DJIA (-1.1%) retreating from recent record highs amid a surge in oil prices and Treasury yields.

Crude oil futures settled today's session $4.33 higher (+4.3%) at $105.49 per barrel amid fears that the U.S. could re-engage in military operations against Iran after the summit between President Trump and President Xi failed to produce any meaningful policy changes.

The lack of surprises from the summit also included no mention of NVIDIA (NVDA 225.32, -10.42, -4.42%) H200 chip sales to China, while China's pledge to purchase 200 Boeing (BA 220.49, -8.72, -3.80%) jets was largely in line with expectations.

More important than any individual stock move, though, was the upward pressure on Treasuries that sent yields to fresh highs for the year amid renewed inflation concerns tied to the rise in oil prices. The 2-year note yield settled up nine basis points to 4.08%, while the 10-year note yield settled up 13 basis points to 4.60%.

Higher interest rates reduce the present value of future cash flows, and the market has clearly been placing a significant premium on the long-term earnings potential tied to the AI buildout.

The PHLX Semiconductor Index finished 4.0% lower today, ending the week with a loss after several choppy sessions. Corning (GLW 191.92, -16.36, -7.85%) and Micron (MU 724.66, -51.35, -6.62%) were among the worst-performing components of the information technology sector (-1.6%).

However, the sector was supported somewhat by relative strength in software stocks, with the iShares GS Software ETF finishing 1.3% higher. Microsoft (MSFT 421.92, +12.49, +3.05%) was a "Magnificent Seven" standout after CNBC reported that Pershing Square has built a position in the company.

Meanwhile, Tesla (TSLA 422.04, -21.26, -4.79%) was a notable laggard, which pressured the consumer discretionary sector (-1.8%).

The sector also faced weakness across its homebuilder components due to rising interest rates, which weighed on building products names in the industrials sector (-1.8%) as well.

The rate-sensitive utilities (-2.4%) and real estate (-1.6%) sectors also underperformed, while the materials sector (-2.7%) finished with the widest loss amid broad weakness in metals and mining names.

Only the energy sector (+2.3%) managed to finish higher amid the surge in oil prices today.

Outside of the S&P 500, the Russell 2000 (-2.4%) and S&P Mid Cap 400 (-1.7%) underperformed amid the broad risk-off tone and renewed pressure on economically-sensitive and rate-sensitive stocks.

Overall, today's session was a reminder that the macro backdrop remains a meaningful headwind for equities even after a strong AI-fueled earnings season helped drive the market to repeated record highs in recent weeks. The market entered the year expecting roughly two Fed rate cuts in 2026, but persistent inflation pressures and the recent surge in oil prices have now shifted expectations toward the possibility of a rate hike next January. The question now is whether investors will once again step in to buy today's weakness across tech and semiconductor stocks, or if rising yields and inflation concerns begin to weigh more meaningfully on the market's momentum.

  • Nasdaq Composite: +12.8% YTD
  • Russell 2000: +12.6% YTD 
  • S&P Mid Cap 400: +9.2% YTD
  • S&P 500: +8.2% YTD
  • DJIA: +3.0% YTD

Reviewing today's data:

  • May Empire State Manufacturing 19.6 (Briefing.com consensus 6.2); Prior 11.0
  • April Industrial Production 0.7% (Briefing.com consensus 0.2%); Prior was revised to -0.3% from -0.5%, April Capacity Utilization 76.1% (Briefing.com consensus 75.7%); Prior 75.7%
    • The key takeaway from the report is that it was underpinned by solid manufacturing output that was led by the production of durables. Excluding motor vehicles and parts, manufacturing output was up 0.3% month-over-month.
16:36  AMR Alpha Metallurgical Resources' Spartan Mining Co. received an imminent danger order issued by the Mine Safety and Health Administration (179.69 -2.24)

The order stated that an accumulation of methane was detected in a cross-cut adjacent to an outby belt entry in a limited high area of the Mine roof. The belt was immediately shut down and adjustments were made to the ventilation controls to eliminate the accumulation. No injuries or property damage occurred in connection with the stated conditions. Immediately after the above actions were completed, the order was terminated.
16:35  CBUS Cibus Global files for $200 mln mixed securities shelf offering (1.31 -0.10)

 
16:32  CATY Cathay Bancorp declares a quarterly cash dividend of $0.38/share for annualized dividend of $1.52/share, up from prior annualized dividend of $1.40/share (55.61 -0.66)

 
16:32  RANI Rani Therapeutics announces the Chief Financial Officer, Svai Sanford, will resign following the appointment of his successor (1.08 -0.03)

  • Rani Therapeutics states Sanford advised the company May 12th, 2026 of his intent to resign.
    • In the interim, Mr. Sanford has agreed to continue serving as Chief Financial Officer during to ensure continuity and support an orderly transition of responsibilities until a successor is appointed or until an earlier date as may be mutually agreed between the Company and Mr. Sanford.
  • Mr. Sanford and the Company have entered into a transition and separation agreement, dated May 15, 2026.
16:30  SRE Sempra Energy files mixed securities shelf offering (90.43 -2.43)

 
16:16  BNTX BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026 (89.55 -2.44)

MAINZ, Germany, May 15, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (BNTX) held its Annual General Meeting today. A total of 92 per cent of the share capital was represented at the virtual assembly. All resolutions proposed on the agenda items put to the vote at today's AGM were approved by a majority of the shareholders.
16:15  RGA Reinsurance Group of America files mixed securities shelf offering (210.12 -1.03)

 
16:12  AGEN Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer (3.58 )

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of Phase 1b data evaluating botensilimab (BOT), an Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, in patients with treatment-refractory hepatocellular carcinoma (HCC) who had progressed following prior immunotherapy. The manuscript, titled "A phase 1b study of botensilimab and balstilimab in treatment-refractory hepatocellular carcinoma," was published in Liver Cancer and is available at DOI: 10.1159/000551630.
16:09  CAEP Cantor Equity Partners III: AIR completes business combination and will begin trading on Nasdaq stock market (15.00 +2.51)

  • AIR Limited, the global leader in flavored shisha molasses and pioneer in advanced inhalation technologies, announces the closing of its previously announced business combination with Cantor Equity Partners III, which was approved by CAEP shareholders at an extraordinary general meeting on May 12, 2026.
  • In connection with the closing of the business combination, the AIR group will be publicly traded under the listing entity, AIR Global PLC, with its ordinary shares set to begin trading on Nasdaq under the ticker symbol "AIIR" on May 18, 2026.
16:07  CADL Candel Therapeutics reports extended clinical benefit over multiple clinical endpoints in patients from Phase 3 trial of Aglatimagene Besadenovec in localized prostate cancer under prolonged follow-up at AUA 2026 Annual Meeting (8.77 -0.14)

NEEDHAM, Mass., May 15, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced new results from extended follow-up of its randomized, double-blind, placebo-controlled pivotal phase 3 trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in intermediate- to high-risk localized prostate cancer. These findings demonstrate consistent clinical benefit across multiple exploratory endpoints, reinforcing the positive topline data announced in December 2024 after an additional 20 months of follow-up, with a cutoff date of March 15, 2026.
16:05  MNST Monster Beverage authorizes new $500 mln share repurchase program (87.09 +1.27)

 

Copyright © Briefing.com. All rights reserved.